Massachusetts Life Sciences Center’s Post

Let's take a look at the voting results

Last month, many of you participated in a LinkedIn poll on the top three EU cities for life sciences. Here are the results: ▪️ 56% voted for Eindhoven, Stockholm, and Amsterdam. ▪️ 38% guessed Düsseldorf, Munich, and Berlin. ▪️ 6% selected London, Paris, and Dublin. All of you were on point, as these cities are in the top-10 list, according to the 2022 Investment Monitor article. However, Eindhoven, Stockholm, and Amsterdam are in the top three spots. 1️⃣ – Eindhoven leads Europe in life sciences due to its strong economic position, renowned expertise, and thriving industry ecosystems. These factors foster innovation, collaboration, and investment opportunities across pharmaceuticals, biotech, medical technology, and animal health sectors. 2️⃣ – Stockholm, Scandinavia's premier cluster, nurtures collaboration among government, industry, and academia. This synergy has led to the establishment of 15-20 new life science companies annually, backed by prestigious academic institutions and vast medical databases. Sweden's framework of individual researcher ownership further supports profitable ventures. 3️⃣ – Amsterdam stands out with its Amsterdam Life Sciences District, promoting open innovation and boosting market activity & investment. Strategic initiatives like Strohm's plant expansion position the region for accelerated growth and make it increasingly attractive to businesses. 🔗 For a deeper look, read the Investment Monitor article: https://lnkd.in/dK-vy-ke #LifeScience #Biotechnology #Innovation

Today, members of the Regional Development Committee (Regionala utvecklingsnämnden) in Region Skåne visited our science park as part of their ambition to visit stakeholders that are key for growth of the region. Petter Hartman provided an update on the Skåne life science cluster and its challenges.   A tough financing climate and a shortage of expertise were highlighted as areas where the sector is struggling today. But there was also room to highlight some good news, such as the launch of the new scale-up program “10xHealth” (in collaboration with SmiLe Incubator), as well as the latest addition to our science park’s property portfolio – a 12,000 square meter laboratory building representing an investment of about half a billion SEK, which will open up for its tenants in the second half of 2024.   During the meeting, it was emphasised that collaboration between public, private, and academic actors is necessary to ensure a strong life science climate going forward. This includes a joint effort to:   - Strengthen the conditions for clinical research. - Invest in preventive and health-promoting measures. - Invest in the supply of expertise in the future. - Facilitate internationalisation and commercialisation.   At Medicon Village, we look forward to continuing to develop Skåne's life science sector, in close collaboration with our politicians in Skåne.    #collaboration #lifescience #sciencepark Region Skåne | Region Skåne – utveckling & innovation | Skånes universitetssjukhus (Skåne University Hospital) | SmiLe Incubator

Combining clinical excellence and IT innovation skills are exactly what is needed to drive our healthcare forward

Manchester has ranked 14 of 41 European Life Sciences Clusters 🧬 In a recent report by JLL on the Life Sciences Industry Real Estate Outlook for 2024, Manchester was ranked 14th when comparing the growth of its life sciences sector against other successful European clusters. Some highlights include ⬇️ 📍Stating that Manchester is at the forefront of innovative treatments to improve patient care and an 'essential part of the UK's bid to be a 'Science Superpower' 🏢How our developments Citylabs and Manchester Science Park are amongst the major dedicated commercial schemes, offering flexible space for scaling companies, as well as Alderley Park and its large amount of life sciences dedicated supply. 👏Manchester has the largest life sciences corporate base in the UK, outside the Golden Triangle. When looking into the detailed sub-sector landscape, Manchester stands out for the number of “drug discovery & development services” companies with the likes of our customers Sai Life Sciences Ltd & Evotec You can read the full report here: https://bit.ly/3VSbGH1 And find out more about our supporting lab space for life science companies here ➡️ https://bit.ly/4cQAuGu

The Clinical Researcher of the Year – The Americas 2024 seeks to uncover talent among #clinicalresearchers across the Americas. This dynamic event encourages candidates to challenge themselves and one another as they showcase their passion and expertise in the field of clinical research. The awards feature various individual and team categories, including #ClinicalResearchCoordinator, #ClinicalTrialManager, Global Project Manager, and #CRAs (at three different levels) for individuals, and #GlobalProject Team, #GlobalPartnership Team, and Start-Up for teams. Additionally, a new category was introduced in 2024: #Decentralized Solutions Individual of the Year, aimed at Digital & Clinical Individuals to assess their understanding of the importance of decentralized solutions in #clinical research. For further information on entry requirements, please visit the website: Overview: Clinical Researcher of the Year - The Americas (pharmatimes.com) Categories: Categories - Clinical Researcher of the Year - The Americas (pharmatimes.com) #clinicalresearch #CROY #clinicalresearchcompetition #PharmaTimes #clinicaltrials #decentralizedsolutions

A very enjoyable afternoon at the Bisnow UK Life Sciences summer event yesterday with two very thought-provoking panel discussions (one of which was expertly moderated by my colleague Chris Xitsas!) It was interesting to hear from experts what the (current) key criteria are to create a successful life sciences cluster, including: access to teaching hospitals, academia, research institutions, transport links, affordable housing, power (and backup power) supply. The need for investment into the wider infrastructure for the players in UK life sciences to thrive is clearly a hot topic and it will be interesting to see what the new Labour government can promise (and deliver!) to encourage this. Some other key takeaways from the event: the influence of AI and data centres on the advances of UK life sciences and tech will be huge; it’s no longer “location location location” but more like “infrastructure  infrastructure infrastructure” with a growing interest in areas outside the golden triangle (so don’t ignore the corridors that link Oxford and Cambridge to London); UK life sciences players need space - space to grow into, space to store, space to collaborate; and the main theme of the day was flexibility at all levels, from incubators to developers to landlords to investors, this is a growing and changing industry and what was important to occupiers even two years ago is different today. There is a real need for connection and collaboration within UK life sciences and tech to create thriving ecosystems.

At this meeting we will explore how regions and cities can work with innovation districts to strengthen economic development and attractiveness.

Breaking Barriers, Shaping Tomorrow- Join the Journey of 25 Transformative Research Projects with AUTH Medical Physics & Digital Innovation Lab! DAY 5 - Introducing GILL GILL, coordinated by ENoLL, the largest network of Living Labs (LL), will develop a pan-European collaboration and learning hub based on the LL principles to become the open innovation framework for all European actors for open gendered innovation. The GILL “LL” will co-create sustainable mechanisms to increase gender responsive smart innovation and entrepreneurship (GRISE) by fixing practices and culture across the European ecosystems. GILL will focus on 4 macro-objectives: a) to enable the organisational and cultural changes, b) to enhance professional development, c) to increase the integration of gender and diversity into product design, technologies and innovation, and d) to allow gendered educational practices. In parallel, GILL actions will act along a matrix of horizontal spheres of innovation (individual & team, tools & methods, innovation & products, societal processes) and three vertical priorities (Health and resilience, Green & Digital transition). Learn More: https://lnkd.in/d6k5Nqa4

Affordable Space + A Bounty of Scientific Talent = A Properly Growing Biotech Ecosystem. "Chicago also ranks #1 as the most cost-effective destination for life sciences office space among its peers. With average rates at 61% less than New York City, 55% less than San Francisco, and 39% less than Boston, Chicago offers unparalleled value for entrepreneurs and established companies alike. This affordability not only enhances the city's appeal but also enables businesses to allocate resources efficiently, fostering sustained growth and success. Beyond its bustling market and affordable infrastructure, Chicago shines as a powerhouse for talent education in the life sciences domain. Ranked second in the nation for educational institutions and fourth for life sciences education, the Chicago metropolitan area boasts 37 institutions offering industry-related programs or majors. This rich ecosystem of academia not only cultivates a skilled workforce but also fuels a culture of discovery and advancement." https://lnkd.in/gvbp9NmQ